Authors: Hamed Ali Ahmad Alshahri, Omaima Farah Al Jabal
Published in: World Advances in Renal Medicine Vol.1, No.3 (2025)
Read the full article

We are proud to share that Mr. Hamed Ali Ahmad Alshahri, a dialysis nurse at Sultan Qaboos Hospital in Salalah, Oman, has published the first FIRAPY-related case report from Oman, marking an exciting milestone for FIRAPY’s expanding global footprint.

Published in World Advances in Renal Medicine—the official journal of the Oman Society of Nephrology and Transplantation—the case highlights FIRAPY’s ability to promote healing of a non-healing ulcer near the vascular access site. Over the course of regular non-invasive therapy, the patient’s wound showed improvements in granulation, inflammation control, and healing progression, offering new hope in the management of chronic wounds in dialysis patients.

Mr. Hamed’s journey with FIRAPY began in 2016, when he was pursuing his master’s degree in the UK. During his clinical training at the New Cross Hospital in Wolverhampton, he encountered FIRAPY in use and was impressed by its impact on hemodialysis patients. In 2019, while continuing his academic training at Cardiff University, he again saw FIRAPY in practice at multiple dialysis centers, reinforcing his belief in its clinical benefits.

In 2021, upon returning to Oman, Mr. Hamed introduced FIRAPY into the local medical system by contacting FIRAPY team. As an active member of the Oman Society of Nephrology and Transplantation, he has also taken steps to share this innovative therapy with the broader nephrology community in Oman.

We are honored to support dedicated professionals like Mr. Hamed, who bring global innovations to local patient care. His work reflects FIRAPY’s mission: to empower healthcare providers worldwide with safe, evidence-based solutions that improve dialysis outcomes and patient quality of life.

We thank Mr. Hamed for his pioneering contribution and look forward to future collaborations in the Middle East and beyond.